Physician profile
Richard Fuller
NPI 1306841002
$712.48
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $184 · 2022: $291 · 2023: $170 · 2024: $67.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $237.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $316.47 | 2021-2024 | Supartz Fx Sodium Hyaluronate, Supartz Fx Sodium Hyaluronate |
| Fidia Pharma USA INC. | $89.15 | 2022-2024 | Hyalgan |
| Horizon Therapeutics Plc | $78.02 | 2021 | |
| Ferring Pharmaceuticals INC. | $71.93 | 2021-2023 | Euflexxa |
| Depuy Synthes Sales INC. | $47.95 | 2021-2022 | |
| Averitas Pharma INC. | $37.66 | 2023-2024 | Qutenza |
| Zimmer Biomet Holdings, INC. | $37.48 | 2022 | |
| Grt US Holding, INC. | $18.49 | 2021 | |
| Avanos Medical | $15.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Fuller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.